Bile Acids: The Unsung Regulators of Your Gut

When most people think about bile, they think about fat digestion. You eat a fatty meal, your gallbladder contracts, bile flows into the small intestine, and fats get emulsified so your body can absorb them. That part is accurate, and it has been understood for well over a century. But bile acids turn out to be far more interesting than simple detergents. Over the past 20 years, researchers have discovered that bile acids act as signaling molecules, essentially functioning like hormones that influence everything from gut motility to blood sugar regulation to the composition of your microbiome. They also play a central role in a condition that flies under the radar far more than it should: bile acid malabsorption, which is a major cause of chronic diarrhea that gets misdiagnosed as IBS in a substantial number of people.

Bile acid basics: where they come from and where they go

Bile acids are synthesized in the liver from cholesterol. This is actually one of the major pathways your body uses to eliminate excess cholesterol. The liver produces two primary bile acids: cholic acid and chenodeoxycholic acid. These are then conjugated (linked) with either taurine or glycine to form bile salts, which are more water-soluble and better at emulsifying fats. The conjugated bile acids are secreted into bile, which is stored and concentrated in the gallbladder between meals (Hofmann & Hagey, 2008).

When you eat, particularly when the meal contains fat, the hormone cholecystokinin (CCK) signals the gallbladder to contract and the sphincter of Oddi to relax, releasing bile into the duodenum (the first part of the small intestine). There, bile acids get to work emulsifying dietary fats into tiny droplets called micelles, dramatically increasing the surface area available for lipase enzymes to do their work. Without adequate bile acids, fat digestion is severely impaired, leading to fat malabsorption, steatorrhea (greasy, foul-smelling stools), and deficiencies in fat-soluble vitamins A, D, E, and K.

Here is the elegant part: your body does not just make new bile acids from scratch every time you eat. About 95% of bile acids are reabsorbed in the terminal ileum (the last section of the small intestine) through specialized transporters and sent back to the liver via the portal vein. This recycling loop is called enterohepatic circulation, and it runs 6 to 10 times per day. Only about 5% of the bile acid pool is lost in stool each day and replaced by new synthesis. This efficient recycling is critical, and when it breaks down, the consequences are significant (Hofmann & Hagey, 2008).

Bile acids as signaling molecules: FXR and TGR5

The discovery that truly changed how scientists view bile acids came in the late 1990s and early 2000s, when researchers identified that bile acids activate specific receptors in cells throughout the body. The two most important are FXR (farnesoid X receptor), a nuclear receptor found in liver cells, intestinal cells, and other tissues, and TGR5 (also called GPBAR1), a membrane receptor expressed in the gut, immune cells, and brown adipose tissue.

FXR activation in the intestine triggers the release of fibroblast growth factor 19 (FGF19), which travels to the liver and tells it to reduce bile acid synthesis. This is a classic negative feedback loop: bile acids in the gut signal back to the liver to slow down production. FXR also influences glucose metabolism, lipid metabolism, and inflammation. Drugs that target FXR are being developed and tested for conditions including non-alcoholic fatty liver disease (NAFLD) and primary biliary cholangitis (Shapiro et al., 2018).

TGR5 activation has different downstream effects. In the gut, TGR5 stimulates the release of GLP-1 (glucagon-like peptide 1) from L-cells, which is the same hormone that GLP-1 medications like semaglutide mimic. This means bile acids naturally participate in blood sugar regulation after meals. TGR5 also influences gut motility, with activation increasing colonic motility and potentially contributing to the laxative effect of bile acids that reach the colon (Alemi et al., 2013). In immune cells, TGR5 activation tends to reduce inflammation, which has implications for inflammatory bowel disease research.

Bile acid malabsorption: the missed diagnosis

Bile acid malabsorption (BAM) occurs when the ileum fails to reabsorb bile acids efficiently, allowing excess bile acids to spill into the colon. Once there, bile acids stimulate water and electrolyte secretion, accelerate colonic motility, and cause watery diarrhea. The diarrhea is typically frequent, urgent, and watery, often worse after meals (especially fatty ones). It can be accompanied by cramping, bloating, and fecal incontinence in severe cases.

BAM is classified into three types. Type 1 results from ileal disease or resection, most commonly seen in Crohn's disease affecting the ileum or after surgical removal of the terminal ileum. Type 2, also called primary or idiopathic BAM, occurs without obvious ileal disease and is thought to involve excessive bile acid production due to impaired FXR-FGF19 feedback. Type 3 is associated with other GI conditions including celiac disease, chronic pancreatitis, small intestinal bacterial overgrowth, and postcholecystectomy states (Walters, 2014).

The key clinical problem is that BAM is drastically underdiagnosed. A systematic review by Wedlake et al. (2009) found that bile acid malabsorption was present in about 25 to 33% of patients who had been diagnosed with IBS-D (diarrhea-predominant irritable bowel syndrome). That is not a trivial number. One in three or four people told they have IBS-D may actually have a bile acid problem that responds to specific treatment. The reason for underdiagnosis is partly that the best diagnostic test, the SeHCAT scan (a nuclear medicine test that tracks a synthetic bile acid), is not available in the United States. American gastroenterologists often use a therapeutic trial of cholestyramine (a bile acid sequestrant) as a diagnostic proxy: if diarrhea improves on cholestyramine, BAM was likely the cause.

The microbiome connection

Bile acids and the gut microbiome have a fascinating bidirectional relationship. When primary bile acids reach the colon (either the small fraction that escapes ileal reabsorption normally, or larger amounts in BAM), gut bacteria modify them. Bacterial enzymes deconjugate bile salts (removing the taurine or glycine) and then perform a reaction called 7-alpha dehydroxylation, converting primary bile acids into secondary bile acids. The two main secondary bile acids are deoxycholic acid (from cholic acid) and lithocholic acid (from chenodeoxycholic acid) (Wahlstrom et al., 2016).

These secondary bile acids have different biological properties than their primary counterparts. Deoxycholic acid, for example, is a more potent activator of TGR5 than primary bile acids. Lithocholic acid is potentially toxic to cells at high concentrations. The ratio of primary to secondary bile acids in the gut can influence gut motility, mucosal inflammation, and even the risk of colorectal cancer, though the cancer link is complex and involves multiple confounding factors (Ridlon et al., 2014).

The relationship runs the other direction too. Bile acids shape the microbiome by creating an environment that favors certain bacterial species over others. Organisms that can tolerate bile (like many Firmicutes) thrive, while bile-sensitive species decline. This is one reason why dramatic changes in diet, especially shifts in fat intake, can alter the microbiome composition: different amounts of bile acids in the gut change the selective pressure on bacterial communities.

Gallbladder removal and bile acid changes

Cholecystectomy (gallbladder removal) is one of the most common surgeries worldwide, and it changes bile acid dynamics in a way that matters for gut function. Without a gallbladder, bile cannot be stored and concentrated between meals. Instead, bile drips continuously from the liver into the duodenum. This means that the timed, concentrated release of bile that normally occurs after eating is replaced by a lower-level, constant flow.

For most people, this adaptation works well enough, and they notice no significant digestive changes after surgery. But about 10 to 20% of patients develop postcholecystectomy diarrhea, which is often caused by bile acid malabsorption (Fort et al., 1996). Without the gallbladder's concentrating and regulating function, more bile acids may reach the colon, triggering the same secretory diarrhea mechanism seen in other forms of BAM. Bile acid sequestrants are often effective for these patients, but the connection is not always made, and some patients endure years of postcholecystectomy diarrhea before being offered a trial of cholestyramine.

What to do if you suspect a bile acid problem

If you have chronic, watery diarrhea, especially if it is worse after fatty meals, urgency is a prominent feature, or you have had your gallbladder removed or have Crohn's disease affecting the ileum, bile acid malabsorption should be on the list of things to discuss with your gastroenterologist. In the US, the most common diagnostic approach is an empiric trial of cholestyramine. If your symptoms improve significantly on a bile acid sequestrant, that strongly suggests BAM was the cause. Serum C4 (7-alpha-hydroxy-4-cholesten-3-one) and FGF19 levels can also provide supporting evidence, though they are not definitive on their own.

Keeping a detailed log of your symptoms, stool patterns, and dietary fat intake can help your doctor assess whether your diarrhea pattern fits a bile acid problem. GLP1Gut can be useful for tracking these patterns over time, giving you and your provider a clearer picture of how symptoms relate to meals and dietary composition.

Treatment with bile acid sequestrants (cholestyramine, colesevelam, or colestipol) can be very effective, but they require some trial and error with dosing and timing. They need to be taken before meals to bind bile acids in the intestine, and they can interfere with the absorption of other medications, so timing matters. Colesevelam is often better tolerated than cholestyramine in terms of taste and GI side effects.

The bottom line on bile acids

Bile acids are one of the most underappreciated players in digestive health. They are essential for fat digestion, but they also regulate metabolism through FXR and TGR5, modulate gut motility, influence the microbiome, and participate in blood sugar control through GLP-1 stimulation. On the clinical side, bile acid malabsorption is a common, treatable condition that is frequently missed because testing is not routine. If you have chronic diarrhea that has not responded to standard IBS treatments, bringing up bile acid malabsorption with your gastroenterologist could be the conversation that finally leads to an answer.